January 31, 2019
Chugai Pharmaceutical will transfer its Japan rights for three dermatological products containing maxacalcitol to Maruho on December 1, 2019, the two companies said on January 30. The three agents are Oxarol Ointment and Lotion for the treatment of keratosis including...read more